NEVRO CORP.
NVRO
NVRO was delisted on the 2nd of April, 2025.
226 hedge funds and large institutions have $6.32B invested in NEVRO CORP. in 2020 Q4 according to their latest regulatory filings, with 49 funds opening new positions, 82 increasing their positions, 70 reducing their positions, and 31 closing their positions.
166% more call options, than puts
Call options by funds: $41.8M | Put options by funds: $15.7M
58% more first-time investments, than exits
New positions opened: 49 | Existing positions closed: 31
27% more capital invested
Capital invested by funds: $4.98B → $6.32B (+$1.34B)
17% more repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 70
8% more funds holding
Funds holding: 210 → 226 (+16)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$130M |
| 2 |
MWNA
Marshall Wace North America
New York
|
+$70.2M |
| 3 |
BlackRock
New York
|
+$38.6M |
| 4 |
JSP
Jackson Square Partners
Larkspur,
California
|
+$33.1M |
| 5 |
TIM
Thornburg Investment Management
Santa Fe,
New Mexico
|
+$26.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HM
HealthCor Management
New York
|
-$93.1M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$86.7M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$41.3M |
| 4 |
Millennium Management
New York
|
-$28.4M |
| 5 |
D.E. Shaw & Co
New York
|
-$25.5M |
NVRO Hedge Fund Activity: Q4 2020 in Review
226 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in NEVRO CORP. (NVRO) for Q4 2020, worth a combined $6.32B — up 27% from $4.98B a quarter earlier.
Buyers outnumbered sellers: 49 funds opened new NVRO positions and 31 closed out — a net gain of 18 holders — while 82 added to existing stakes and 70 trimmed.
The largest buyer was Capital Research Global Investors, opening a new position worth an estimated $130M. The largest seller was HealthCor Management, cutting an estimated $93.1M.
- 226 institutional investors held NEVRO CORP. (NVRO) as of Q4 2020, up from 210 in Q3 2020.
- Funds reported $6.32B of NEVRO CORP. stock for Q4 2020, up 27% quarter-over-quarter.
- 49 funds opened new NEVRO CORP. positions in Q4 2020 and 31 closed out, a net change of +18 holders.
- The largest NEVRO CORP. buyer in Q4 2020 was Capital Research Global Investors, an estimated $130M added.
- The largest NEVRO CORP. seller in Q4 2020 was HealthCor Management, an estimated $93.1M sold.
Based on aggregated 13F filings for Q4 2020.